Lilly Fasidotril Hypertension Filing Expected By 2006; CHF Two Years Later
Executive Summary
Lilly plans to file a fasidotril NDA for hypertension in 2005-2006 through an agreement with the Parisian biotech company Bioprojet, Exec VP-Science & Technology August Watanabe, MD, told analysts